Joerg Alte
Corporate Officer/Principal bei FIDEsprit AG
Profil
Joerg Alte has served as a Director of Proteo, Inc. since December 2000 and Managing Director of FIDEsprit AG since September 2007.
He served as President, Chief Executive Officer and Chief Financial Officer of Proteo from 2000 to 2003.
Mr. Alte is a German Lawyer by training and practice.
Mr. Alte worked as a Legal Advisor with a German diagnostic company, where he practiced German and US securities laws.
From November 1998 to April 2000, he served as President and Chief Executive Officer of Sangui Biotech International, Inc.
Aktive Positionen von Joerg Alte
| Unternehmen | Position | Beginn |
|---|---|---|
| FIDEsprit AG | Corporate Officer/Principal | 01.09.2007 |
Ehemalige bekannte Positionen von Joerg Alte
| Unternehmen | Position | Ende |
|---|---|---|
| SANGUI BIOTECH INTERNATIONAL, INC. | Präsident | 01.04.2000 |
| PROTEO, INC. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SANGUI BIOTECH INTERNATIONAL, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Proteo, Inc.
 Proteo, Inc. Pharmaceuticals: MajorHealth Technology Proteo, Inc., a clinical stage drug development company, intends to develop, promote, and market pharmaceuticals and other biotech products. The firm focuses on the development of anti-inflammatory treatments for rare diseases. Its proprietary product Elafin, a human protein that naturally occurs in human skin, lungs, and mammary glands. The company's product is intended for the treatment of post-surgery damage to tissue, pulmonary hypertension, serious injuries caused by accidents, cardiac infarction, and other diseases, as well as for the complications resulting from organ transplantation. It has a license and collaboration agreement with ARTES Biotechnology GmbH to produce Elafin by using the sublicensed yeast HANSENULA POLYMORPHA. The company was founded by Oliver Wiedow and Birge Bargmann on December 18, 1992 and is headquartered in Irvine, CA. | Health Technology |
| FIDEsprit AG |
